Sign inJoin waitlistJoin the waitlist

Ari Green

Professor · University of California (San Francisco) School of Medicine

Credentials: · · · ·

History

University of California (San Francisco) School of Medicine
Present

Neurology
UCSF Medical Center
2002–2006
Duke University School of Medicine
1997–2001

Research

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
Case report · New England Journal of Medicine · 2005 · 808 citations
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Review · Nature Reviews Neurology · 2022 · 653 citations
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
The Lancet · 2019 · 587 citations

Jeffrey Gelfand
50 papers · 6 as a resident
BC
Bruce Cree
47 papers
Stephen Hauser
40 papers
CC
Christian Cordano
37 papers
AA
Ahmed Abdelhak
33 papers
Peter Calabresi
23 papers
Riley Bove
23 papers
SZ
Scott Zamvil
19 papers
EW
Emmanuelle Waubant
18 papers
Jennifer Graves
17 papers · 1 as a fellow
SS
Shiv Saidha
17 papers
Michael Wilson
16 papers

Grants

MR Metabolic Imaging of Multiple Sclerosis
National Institute of Neurological Disorders and Stroke · R01
PI · $1.7M · University of California, San Francisco
2017–2029
Establishing VEP as a Quantitative Biomarker for Remyelination Using Transgenic Models for Gain and Loss of Function
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.8M · University of California, San Francisco
2018–2023

Clinical trials

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy
Principal investigator · Not yet recruiting · Phase 1, Phase 2
University of California, San Francisco
2026–2028
Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
Principal investigator · Recruiting · Phase 2
Ari Green
2026–2029
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Principal investigator · Recruiting · Phase 1, Phase 2
University of California, San Francisco
2023–2027
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
Principal investigator · Recruiting · Phase 2
University of California, San Francisco
2017–2028